Status:
COMPLETED
Effect of High-intensity Interval Training on Cardiac Function and Regulation of Glycemic Control in Diabetic Cardiomyopathy
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
Jessa Hospital
Conditions:
Diabetic Cardiomyopathies
Type2 Diabetes
Eligibility:
All Genders
18-81 years
Phase:
NA
Brief Summary
According to data of the International Diabetes Federation (IDF), diabetes in general affects approximately 415 million people worldwide and this number is still increasing. Cardiovascular diseases, o...
Eligibility Criteria
Inclusion
- type 2 diabetes patients:
- BMI \> 20kg/m²
- diagnosis of T2DM as stated in guidelines of ADA (American Diabetes Association)
- stable medication for at least 3 months
- Healthy controls:
- BMI \> 20kg/m²
- no diabetes
Exclusion
- iron deficiency anemia
- participation in another clinical trial
- heart diseases: CAD (coronary artery disease), ischemia, valvular diseases, congenital heart diseases
- neurological, pneumological, oncological, orthopedic disorders
- diabetes complications: renal diseases, retinopathy
Key Trial Info
Start Date :
October 6 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT03299790
Start Date
October 6 2017
End Date
September 30 2020
Last Update
December 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Ziekenhuis
Hasselt, Belgium, 3500